OACC — Oaktree Acquisition Corp. III Life Sciences
—
Nasdaq ·
Financials ·
Diversified Financial Services ·
CIK 2029769 ·
Last close
$10.78
Market Cap
$213.26M
52W High
$10.88
52W Low
$10.45
ADV30
27,990
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -261,958 | 1,604,621 | 206,540,698 | 1,179,670 | 8,748,581 |
| Mar 2026 | 0 | — | -456,538 | 1,394,121 | 204,830,388 | 1,276,930 | 8,642,892 |
| Dec 2025 | 0 | — | -255,496 | 1,788,948 | 203,111,772 | 1,434,965 | 8,318,397 |
| Sep 2025 | 0 | — | -225,579 | 1,966,742 | 201,249,963 | 1,328,841 | 8,245,536 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-504,552
Investing CF
$250,000
Financing CF
—
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.29
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-7,227,233
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-1,207,423
Pretax Income TTM
$7,024,154
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,195,687 | 7,288,824 | 203,111,772 | 8,318,397 | 194,793,375 | -422,079 |
| Dec 2024 | — | — | — | 195,250,622 | 7,746,071 | 187,504,551 | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TVAI | Thayer Ventures Acquisition Corp II | $213.07M | $10.40 | — |
| AXIN | Axiom Intelligence Acquisition Corp 1 | $213.00M | $10.34 | — |
| TDAC | Translational Development Acquisition Corp. | $209.89M | $10.87 | — |
| NHIV | NewHold Investment Corp IV | $208.70M | $10.05 | — |
| XSLL | Xsolla SPAC 1 | $208.32M | $9.98 | — |
Recent Insider Activity
No insider activity indexed for this ticker.